Bangladesh Administers Oral Polio Vaccine To 22 Million Children
This article was originally published in PharmAsia News
Executive Summary
In the first of two rounds of doses, Bangladesh authorities gave 22 million children an oral vaccine against polio and followed up with a house-to-house canvass to make sure no child was overlooked. The second round of the oral polio vaccines is set for Jan. 3. About 600,000 health care workers and volunteers also were vaccinated and children under five were given vitamin A capsules as part of the program to immunize all children under the age of five. The country counted 18 polio cases two years ago, spurring the strong immunization effort. (Click here for more
You may also be interested in...
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.